Latest Breaking News On - Adding durvalumab to concurrent chemoradiation - Page 1 : comparemela.com

Durvalumab/chemoradiation did not significantly improve survival vs chemoradiation alone in patients with unresectable non–small cell lung cancer.

United statesCzech republicUniversity of pennsylvaniaJeffreyd bradleyHospital of the university pennsylvaniaEuropean lung cancer congressProton therapy technology developmentWorld health organizationLung cancerProton therapyTechnology developmentEastern europeLung cancer congressAdding durvalumab to concurrent chemoradiationPatients with unresectable stage iii non small cell lung cancer